Adapting to the AI Era: Simulating Patient and Physician Perspectives at Scale
As recently profiled in the New York Times, the rise of AI chatbots in healthcare is fundamentally changing how patients form […]
Blog
Is AI at the helm of biopharma business development strategies?
Jacqueline Poot President – Strategic Consulting & Analytics BU IDEA Pharma As a moderator of this session at BIOEuropeSpring, my
Minimizing Risk and Maximizing Insight: A Conversation on AI in Market Research
Minimizing Risk and Maximizing Insight: A Conversation on AI in Market Research AI is reshaping market research and consulting—improving hypothesis
Humanizing AI to Improve Market Research Outcomes
Market research teams are under more pressure than ever. Timelines are shrinking. Budgets are tightening. Expectations for certainty keep rising
The Emerging Innovative Pharmaceutical Enterprises in China
Building on the China Pharmaceutical Innovation and Invention Index, which assesses the overall innovation strength of leading Chinese pharmaceutical companies, here
Fulcrum Research Group and Synthetic Users
What it is: Synthetic Users built for pharma research: AI that behaves like real, emotional respondents. Exclusive to Fulcrum Research and SAI.
Revitalizing Pharma Collaborations: The Reblozyl Case Study
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the
Don’t Let Your Tracker Get Stale: An Interview with Lucy Robin
Don’t Let Your Tracker Get Stale: An Interview with Lucy Robin By The Fulcrum Research Division Lucy Robin is one
Pioneering the Future of Cardiovascular Treatment with Sekar Kathiresan
In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about
Decision Frameworks in Pharma: From RAVE and DICE to Lilly’s Truth-Seeking Machine
What Works, What Kills What, and Why It Matters By Mike Rea In pharmaceutical R&D, where billions ride on the